Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Studies offer new treatment option to prevent kidney rejection

30.10.2002


A new study of the most commonly prescribed post-kidney transplant drug suggests it may not be the most effective weapon to fend off organ rejection and may even damage some donor kidneys. The research, to be presented Nov. 2 at the American Society of Nephrology annual meeting, identified another drug that seems to work better, a finding that could help expand the pool of donor organs.



An analysis by an Ohio University physiologist suggests that large doses of cyclosporine, the most often used anti-rejection drug, could cause a drop in the rate at which the kidney filters blood and decrease blood flow to the kidney. For patients who receive what’s known as a "marginal kidney," problems with cyclosporine may be particularly dangerous, the study found. A shortage of donor kidneys has prompted doctors to consider the use of organs from people who had high blood pressure or other health problems, as well as donor kidneys from non-heart beating donors. These marginal kidneys once were presumed to have higher failures rates, but research now suggests that the majority of them fare as well as any other transplanted organ. But such kidneys may be more prone to ischemia-reperfusion injury, tissue damage that occurs when blood flow to an organ is stopped, then started again after a period of time. The injury is common in all kidney transplants, but may be particularly severe in patients who receive marginal kidneys.

"More hospitals are starting to use marginal kidneys more often," said Sharon Inman, lead author of the study and assistant professor of biomedical sciences in the university’s College of Osteopathic Medicine. "We want to see if we can make those kidneys exposed to ischemia-reperfusion injury work better so we can use them for transplant."


Inman is studying the effectiveness of rapamycin, a new immunosuppressant that controls the immune system differently than its more widely used counterpart and, according to Inman’s preliminary findings from a study in rats, may do so without harming the kidney.

"The kidneys treated with cyclosporine fared much worse that those treated with rapamycin," Inman said, adding that those organs suffered more restricted blood flow and poorer kidney filtration. This study followed the rats for five to seven days; the next step in the project is to follow them for a longer period of time. Inman also is interested in studies that suggest certain cholesterol-lowering drugs may improve renal function, and is launching another project to see if cholesterol medication can counteract the negative effect cyclosporine can have on the kidneys.

Last year, 14,152 people in the United States received a donor kidney, according to the United Network for Organ Sharing. But more than four times that number ended the year on the national organ transplant waiting list and another 2,861 died before a match could be found.

The use of marginal kidneys as a donor alternative may be more common today, but they still accounted for less than 2 percent of all organ transplants in 1999, the most recent year for which UNOS has data.

And the practice is not without controversy. Some of those kidneys come from non-heart beating donors – patients who, although they are not brain dead, could not survive without life-support equipment. Some claim this encourages the premature ending of the life of the donor. Others point to the two criteria used by many doctors for determining death: heart oriented and brain oriented. Scientists and physicians are now pushing for a uniform policy written by non-transplant specialists that would be instituted at all transplant centers.

"It’s crucial that the public is aware and understands the endpoint of death," Inman said. "This is important since ’marginal’ organs, such as those retrieved from non-heart beating donors, could expand the donor pool."

Inman’s studies are supported by a National Kidney Foundation Young Investigator Grant. The research was co-authored by Nancy Davis, a research technician, and Kristen Olson and Vicky Lukaszek, juniors in pre-med studies, all at Ohio University.

Kelli Whitlock | EurekAlert!
Further information:
http://www.ohio.edu/researchnews/

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>